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Introduction 
The systemic inflammatory response syndrome (SIRS) is 
a serious, life-threatening clinical condition. The 
prevalence of SIRS is high, affecting one-third of all 
hospitalized patients.  
In cardiac surgery, pre-existing disorders (e.g., poor left 
ventricular function, diabetes) and surgical factors (e.g., 
sternotomy, pericardectomy or cardiac ischemia) can 
cause a pathological inflammatory response and 
concomitant organ dysfunction. In addition, the extra-
corporeal circulation (ECC) is considered as a cause of 
SIRS. The contact of blood with air and the foreign 
surfaces included in the ECC circuit triggers a complex 
cascade of reactions that involve the inflammatory, 
clotting and complement systems. The coincidence of 
potential confounders (e.g., advanced age, pre-operative 
health condition, perfusion technique) may further act 
unfavorably, which can lead to a dysbalance of pro- and 
anti-inflammatory pathways and the subsequent 
development of SIRS.  
Interventional cardiology procedures include trans-
catheter aortic valve implantation (TAVI) via the trans-
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femoral (TF-TAVI) or the transapical route (TA-TAVI). 
Although in TAVI an ECC is avoided, SIRS remains a 
common phenomenon. SIRS in TAVI occurs in 40-60 % 
of affected individuals and is independently associated 
with worse short-term outcome and mortality. In contrast 
to the mechanisms in cardiac surgery, SIRS pathogenesis 
and triggering factors have not been completely 
identified in TAVI. Currently, intra-procedural low 
cardiac output states are considered partially accountable 
for the induction of ischemic organ injury and for SIRS. 
 
Objectives 
The aim of this doctoral thesis is to provide a detailed 
insight into the inflammatory response and the changes in 
immune sensitivity that occur in the peri-operative period 
during different cardiac surgery and interventional 
cardiology procedures.  
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Study 1. Assessment of the immune sensitivity in cardio-
pulmonary bypass procedures using CD62L shedding 
assay. The aim of was to investigate changes in the peri-
operative immune sensitivity in patients scheduled to 
undergo cardiac surgery by using conventional extra-
corporeal circulation (CECC). The main focus was on 
CECC-induced immunomodulation, which was 
determined by the quantification of molecules that are 
involved in immune reactions (i.e., interleukins). In 
addition, the functional status of the immune system was 
determined by using a novel method to assess the 
responsiveness of inflammatory effector cells. This 
method, referred to as the CD62L shedding assay, 
quantifies the cleavage of the adhesion molecule L-
selectin (CD62L) from the surface of neutrophils after 
microbial stimulation, thereby providing information on 
granulocyte and monocyte sensitivity.  
Study 2. Investigation of inflammatory response to 
treatment of AS. The aim was to investigate patients with 
severe symptomatic aortic valve stenosis (AS) for the 
inflammatory response in the perioperative course. The 
main focus lay in the comparison of cardiac surgical and 
interventional cardiology modalities in the treatment of 
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AS. Whereas surgical aortic valve replacement (SAVR) 
using CECC represents the current gold standard, TAVI 
become widely available for selected high-risk patients 
with multiple co-morbidities allowing the treatment of 
AS without the use of ECC.  
Study 3. Investigation of inflammatory response to 
surgical treatment of AS. This study investigated the 
inflammatory response occurred in patients treated solely 
surgically for AS. The main focus lay on the comparison 
of CECC with its less invasive variant, the minimized 
extracorporeal circulation (MECC).  
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Methods 
Cardiac surgery and interventional cardiology procedures 
were performed according to institutional standards. 
Determination of inflammatory markers and CD62L 
shedding were performed after 4 (Study 2 and 3), 24 
(Study 2 and 3) and 48 hrs (Studies 1, 2 and 3) post-
operatively. The first blood sample (baseline value) was 
drawn before the procedures and prior to the application 
of anesthetic drugs.  
The CD62L shedding assay. For the CD62L shedding 
assay 25 ml citrate whole blood was stimulated with 25 
ml of six 10-fold dose-titrations starting at 10 mg/ml 
(Lipoteichoic acid, LTA), 20 ng/ml (tumor necrosis 
factor, TNF). After 45 min. incubation at 37 °C / 5 % 
CO2, cells were washed in PBS/BSA 1 % and stained 
with 25 ml PBS/BSA 1 % containing APC-anti-human 
CD33 and FITC-anti-human CD62L antibodies for 15 
min. Red blood cells were lysed in 200 ml FACS Blood 
monocytes and granulocytes were distinguished on the 
basis of CD33 expression and side scatter. Median FITC 
fluorescence intensity is computed for each sample’s 
granulocytes and monocytes and plotted against dilution 
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factor to enable parallel analysis of multiple agonists. 
Four-parameter curves are fitted using non-linear 
regression and LogEC50 values were extracted, 
corresponding to the dilution factor giving 50 % 
granulocyte or monocyte CD62L-shedding. The 
corresponding ligand concentration was calculated and 
plotted for each ligand. 
HLA-DR expression. For human leukocyte (HLA-DR) 
expression 50 µL of heparinized blood were stained with 
20 µL of anti-human-HLA-DR at room temperature in 
the dark for 25 min. Red blood cells were subsequently 
lysed with FACS lysis solution and washed twice with 
phosphate-buffered saline solution and fixed with 400 µL 
of 4 % paraformaldehyde. The fluorescence intensity of 
the samples was measured on an LSR II as duplicates. A 
total of 500-1,000 monocyte events were recorded. The 
FACS data were analyzed with gating for CD14- and 
CD64-positive monocytes. The HLA-DR channel was 
calibrated using the data from the PE beads, which allows 
fluorescence intensity to be correlated with the mean 
number of PE molecules per cell. The results were 
recorded as the median of the calibrated PE channel 
fluorescence intensity of each sample.  
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Cytokine level measurement. Determination of cytokines 
(IL-6, IL-8, IL-10) was performed by ELISA in patients` 
plasma from each time point, which was separated from 5 
mL of EDTA-whole blood by centrifugation at 3,000 g 
for 5 min and stored at -80 °C.  
sCD62L level measurement. Soluble L-selectin 
(sCD62L) levels were measured by ELISA. The provided 
96-well plate was treated according to the manufacturer’s 
instructions, and all standards, controls and samples were 
loaded in duplicate. Optical density was measured using 
an eL800 microplate reader set to record at 450 and 630 
nm. Blank values and OD values at 630 nm were 
subtracted from all OD 450 nm values, and the sCD62L-
selectin concentration of all samples was determined by a 
4-parameter curve fit of the standards. 
sTLR-2 measurement. Soluble toll-like receptor (sTLR)-2 
concentrations were detected using a human TLR-2 
ELISA kit. The detection range (standard curve) was 
0.312–20 ng/ml, intra- and inter-assay variation was 
given as 8 and 10 % CV by the manufacturer. For 
ADAM17 all samples were measured undiluted using a 
TACE human ELISA kit according to the manufacturer’s 
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instructions. The detection range (standard curve) was 
78.15 – 5000 pg/ml, intra- and inter-assay variation was 
given as 10 and 12 % CV. 
 
Results 
Study 1. Assessment of the immune sensitivity in cardio-
pulmonary bypass procedures using CD62L shedding 
assay. Granulocyte and monocyte sensitivity to LTA 
decreased at the end of cardiac surgery but re-covered to 
the baseline after 48 hrs. Decreased immune sensitivity 
was apparent as a roughly 10-fold increase of the initial 
LTA concentration was necessary to cause shedding of 
50 % of CD62L from the cell surface of granulocytes or 
monocytes. 
TNF stimulation of granulocytes showed a decreased 
sensitivity at the end of cardiac surgery as revealed by a 
10-fold increased TNF concentration required to produce 
50 % shedding of the membrane-bound fraction of 
CD62L. In contrast, monocyte sensitivity were not 
diminished at the end of surgery and after 48 hrs. 
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Median density of surface HLA-DR decreased 
significantly at the end of surgery. After 48 hrs monocyte 
density did not recover to the baseline, but rested reduced 
in comparison to the first sampling time point. 
IL-8 levels significantly increased at the end of surgery 
as compared to the first sampling point. After 48 hrs. IL-
8 decreased in comparison to the sampling point at the 
end of surgery, however, the preoperative value was not 
reached. The IL-8 concentration after 48 hrs was still 
significantly increased when compared to the first 
sampling time point. 
sCD62L plasma levels significantly decreased at the end 
of surgery. After 48 hrs the levels were still lower as at 
the first sampling time point indicating that sCD62L did 
not reach pre-operative values after 48 hrs. 
sTLR-2 showed a significant increase at the end of 
surgery. After this peak sTLR-2 levels decreased to a 
minimum at 48 hrs showing a significant difference to 
values at the end of surgery.  
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ADAM17 levels increased constantly during the peri-
operative course, however, a significant difference 
between two sampling points cannot be detected.  
Study 2. Investigation of inflammatory response to 
treatment of AS and Study 3. Investigation of 
inflammatory response to surgical treatment of AS. The 
plasma level of HLA-DR showed a different course 
within the four treatment modalities. The highest baseline 
value of HLA-DR was detected in MECC patients. In this 
population HLA-DR decreased continuously having 
different values from the baseline at all sampling points. 
CECC, TF-TAVI and TA-TAVI patients exhibited much 
lower HLA-DR values. In CECC and TA-TAVI patients 
HLA-DR levels were different from the baseline at all 
sampling points. In TF-TAVI patients HLA-DR values 
decreased significantly from the baseline at 4 hrs. and 24 
hrs. After 48 hrs, HLA-DR levels in TF-TAVI were not 
significantly different from the baseline.          
The plasma level of IL-6 showed a different course 
within the four treatment modalities. The highest increase 
was detected in the TA-TAVI group peaking at 4 hrs 
post-operatively. TA-TAVI, MECC and CECC groups 
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peaked also within 24 hrs post-operatively, however at 
lower levels. The most attenuated IL-6 release was 
measured in the TF-TAVI group having only a slight 
increase in the observation period. In all groups IL-6 
plasma levels were different from the baseline. At the end 
of the observation period no group returned to the pre-
operative baseline. IL-8 showed a different course within 
the four treatment modalities. The highest increase was 
noted at 4 hrs post-operatively in the CECC group, 
followed by MECC group. TF-TAVI and TA-TAVI 
peaked at 4 hrs and 24 hrs. In the patient population 
undergoing interventional treatment, no significant 
differences were noted in the observation period. In 
contrast, the changes in the IL-8 plasma level in the 
CECC and MECC group were significantly different 
during the peri-operative course. In the MECC group IL-
8 plasma level at 4 hrs and at 48 hrs was significantly 
different from the baseline. In the CECC group IL-8 was 
significantly different from the baseline at 4, 24 and 48 
hrs. In contrast to the interventional treatment, in 
surgically treated patients IL-8 values did not return to 
the baseline at the end of the observation period. IL-10 
did not show a different course within the four treatment 
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modalities. Highest IL-10 values were detected in the 
CECC group, followed by MECC treatment. In the inter-
ventional groups IL-10 peaked at 4 hrs with TA-TAVI 
and at 24 hrs with TF-TAVI, however with lower values 
as in the surgical groups. With interventional treatment 
IL-10 plasma levels were significantly different from the 
baseline at 4 hrs and at 24 hrs. In both groups IL-10 
levels returned to the baseline at the end of the 
observation period. Likewise, IL-10 levels in MECC 
patients were not significantly different at the sampling 
points and at the end of the observation period. In the 
CECC population, IL-10 was different from the baseline 
at 4 hrs and at 24 hrs. At the sampling point at the end of 
the observation period, however, the IL-10 levels of 
CECC patients did not differ from the baseline.  
sCD62L showed a different course within the four 
treatment modalities. Highest values were detected in the 
MECC, followed by the CECC group. In the MECC 
sCD62L values only at 4 hrs. and 48 hrs. were different 
from the baseline, whereas in the CECC sCD62L values 
at all sampling points were different from the baseline. 
Thus, surgically treated patients did not return with 
sCD62L to the baseline at the end of the observation 
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period. Interventionally treated patients did not show 
peaks in sCD62L levels in the observation period.     
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Conclusions 
 The results of this work indicate that SIRS and 
associated decreased immunity is present in all 
cardiac surgery and interventional cardiology 
procedures. 
 The extent of peri-operative immunomodulation 
is detectable with both conventional inflammatory 
markers and the CD62L shedding assay. 
Moreover, the application of this assay provides 
additional information to the extent of peri-
operative immunomodulation and contributes to a 
better understanding of peri-procedural 
inflammatory modulations. 
 The impact of ECC on the inflammatory response 
is evident. 
 Patients who are treated with CECC show the 
most pronounced inflammatory response. 
 In patients undergoing TF-TAVI, only a 
diminished inflammatory response is detectable. 
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 The use of an extracorporeal circuit is not the sole 
factor that influences the extent of inflammatory 
molecule release. 
 Likewise, patients pre-treatment condition and the 
extent of myocardial trauma affect the 
inflammatory course. 
  The time-course and the extent of inflammatory 
response after a specific treatment modality do 
not predict the post-operative course, and there is 
no direct link to patient outcome. 
 According to our results, the investigated 
variables (e.g., CECC, MECC, TAVI) represent 
only one factor amongst others that may influence 
the post-operative patient course.  
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